Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
PCVX — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

9.32

Margin Of Safety %

Put/Call OI Ratio

2.31

EPS Next Q Diff

-0.05

EPS Last/This Y

-1.76

EPS This/Next Y

0.1

Price

60.06

Target Price

109

Analyst Recom

1.2

Performance Q

34

Upside

-223.5%

Beta

1.45

Ticker: PCVX



21 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-09PCVX59.292.040.5017292
2026-03-10PCVX58.251.996.0017887
2026-03-11PCVX57.541.990.0017878
2026-03-12PCVX56.211.996.0017877
2026-03-13PCVX56.211.996.0017877
2026-03-17PCVX55.451.980.5024687
2026-03-18PCVX54.322.102.3025664
2026-03-19PCVX53.961.950.1330503
2026-03-20PCVX54.71.951.9530502
2026-03-23PCVX55.932.292.0627211
2026-03-24PCVX54.642.2976.7128472
2026-03-25PCVX55.922.352.2228995
2026-03-26PCVX54.692.371.6036786
2026-03-27PCVX53.122.3515.1039450
2026-03-30PCVX54.942.372133.4039641
2026-03-31PCVX58.072.540.5841738
2026-04-01PCVX58.512.362.0939676
2026-04-02PCVX58.362.312.3349135
2026-04-06PCVX59.872.3122.0049141
2026-04-07PCVX60.72.310.0849164
2026-04-08PCVX60.162.310.0149188
DateSymbolLatestP/C OIP/C VolTotal OI
21 items Current Page1 of 1



21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-09PCVX59.27-70.6- -7.39
2026-03-10PCVX58.24-70.6- -7.14
2026-03-11PCVX57.54-70.6- -7.14
2026-03-12PCVX56.18-70.6- -7.14
2026-03-13PCVX54.60-70.6- -7.14
2026-03-17PCVX55.47-70.6- -7.14
2026-03-18PCVX54.32-70.6- -7.14
2026-03-19PCVX53.98-70.6- -7.14
2026-03-20PCVX54.72-70.6- -7.14
2026-03-23PCVX55.93-70.6- -7.14
2026-03-24PCVX54.63-70.6- -7.14
2026-03-25PCVX55.92-70.6- -7.14
2026-03-26PCVX54.72-70.6- -7.14
2026-03-27PCVX53.16-70.6- -7.14
2026-03-30PCVX54.94-70.6- -7.14
2026-03-31PCVX58.07-70.6- -7.14
2026-04-01PCVX58.53-70.6- -7.14
2026-04-02PCVX58.37-70.6- -7.39
2026-04-06PCVX59.81-70.6- -7.39
2026-04-07PCVX60.73-70.6- -7.39
2026-04-08PCVX60.06-70.6- -7.39
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1



21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-09PCVX-0.574.759.81
2026-03-10PCVX-0.574.759.81
2026-03-11PCVX-0.844.759.45
2026-03-12PCVX-0.844.759.45
2026-03-13PCVX-0.844.759.45
2026-03-17PCVX-0.844.739.45
2026-03-18PCVX-0.844.739.45
2026-03-19PCVX-0.894.739.45
2026-03-20PCVX-0.894.739.45
2026-03-23PCVX-0.894.849.45
2026-03-24PCVX-0.894.849.45
2026-03-25PCVX-0.894.849.32
2026-03-26PCVX-0.894.849.32
2026-03-27PCVX-0.894.849.32
2026-03-30PCVX-0.894.849.32
2026-03-31PCVX-0.894.849.32
2026-04-01PCVX-0.894.849.32
2026-04-02PCVX-0.894.849.32
2026-04-06PCVX-0.954.849.32
2026-04-07PCVX-0.954.849.32
2026-04-08PCVX-1.034.849.32
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

-1.8

Avg. EPS Est. Current Quarter

-1.77

Avg. EPS Est. Next Quarter

-1.85

Insider Transactions

-1.03

Institutional Transactions

4.84

Beta

1.45

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

8

Growth Score

19

Sentiment Score

97

Actual DrawDown %

50.4

Max Drawdown 5-Year %

-76.2

Target Price

109

P/E

Forward P/E

PEG

P/S

P/B

2.93

P/Free Cash Flow

EPS

-5.71

Average EPS Est. Cur. Y​

-7.39

EPS Next Y. (Est.)

-7.29

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

1.07

Return on Equity vs Sector %

-55.8

Return on Equity vs Industry %

-39.4

EPS 1 7Days Diff

-0.3

EPS 1 30Days Diff

-1.21

EBIT Estimation

◆ PCVX Healthcare
$60.10
📉
Swing / Pullback
Buy the dip on strong trends
50 /100
WEAK
Trend
20/20
Pullback
10/25
Volume
4/15
Valuation
8/20
TP/AR
4/10
Options
4/10
RSI
60.2
Range 1M
83.6%
Sup Dist
1.6%
🚀
Momentum Growth
Ride accelerating trends
42 /100
WEAK
Momentum
20/25
Growth
5/30
Estimates
4/20
Inst/Vol
9/15
Options
4/10
EPS Yr
-28%
EPS NY
1.7%
52W%
89.6%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +81.4% upside
Quality
2/30
Valuation
14/30
Growth
2/25
Stability
9/10
LT Trend
4/5
Upside
+81.4%
Quality
8
Click a card to see score breakdown Full Analysis →
Vaxcyte, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 507
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria; and VAX-XL, a third-generation pneumococcal conjugate vaccine. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
PCVX

Latest News

—
Caricamento notizie per PCVX…
stock quote shares PCVX – Vaxcyte, Inc. Stock Price stock today
news today PCVX – Vaxcyte, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PCVX – Vaxcyte, Inc. yahoo finance google finance
stock history PCVX – Vaxcyte, Inc. invest stock market
stock prices PCVX premarket after hours
ticker PCVX fair value insiders trading